Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking

NCT ID: NCT06546618

Last Updated: 2025-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-14

Study Completion Date

2025-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research is to determine how removal of little cigar and cigarillo (LCC) flavor descriptors on packaging impacts attention and affective responses to LCC warnings. A study will be conducted using eye tracking, electrodermal activity (galvanic skin response), and survey measures of affect to measure participant responses to LCC packages varied by warning type (pictorial vs. text only) and flavor contents ('Sweet' flavor descriptor vs. no flavor descriptor).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over 4 million US adults regularly smoke cigars, which causes multiple cancers, including oral, esophageal, pancreatic, laryngeal, and lung cancer. Even smoking 1-2 cigars per day is associated with elevated cancer risk. Though cigarette consumption decreased 39% from 2000 to 2015, cigar consumption increased 85%. Of the three major types of cigars-large cigars, little cigars, and cigarillos-little cigars and cigarillos (LCC) are the most commonly used in the US. LCC use among adults has increased in part because LCCs are taxed at a lower rate than cigarettes, are subject to fewer regulations and marketing restrictions, can be purchased in small pack sizes, and are exempt from flavor bans that apply to cigarettes.

In May 2016, the Food and Drug Administration (FDA) required text-only warnings on LCC packs, rotating among six statements. Research on cigarettes suggests warnings on packs should have multiple rotating sets, contain images illustrating the negative health effects associated with LCC use, and be large. However, the evidence for cigarette warning labels cannot adequately inform implementation of improved LCC warnings for four reasons: 1) The currently mandated cigar warnings differ from existing cigarette warnings; 2) there is no evidence on the effectiveness of the currently mandated cigar warnings (i.e., behavioral intentions or outcomes) or evidence on efforts that might improve LCC warnings (i.e., images, larger warning size, removal of LCC flavor descriptors on packaging); 3) Courts have ruled that one type of effective tobacco warning (i.e., for cigarettes) cannot be used to justify other types of tobacco warnings, such as those for LCCs and 4) LCC users have different demographic and consumption profiles than cigarette users (i.e., LCC users include a higher proportion of young adults African Americans, and LCCs are used on fewer days per month, which should be taken into account when developing improved warnings.

Gaps exist in understanding how LCC policies, such as the removal of flavor descriptors on packaging, influence the impact of LCC warnings. This eye tracking and psychophysiology project will provide new data to fill these evidence gaps and advance general scientific knowledge about elements of tobacco warnings research.

During the study, Participants will see 12 LCC pack stimuli images presented in random order. 3 packs will feature pictorial LCC warnings and a "Sweet" flavor descriptor, and the same 3 warnings will be presented on packs without a flavor. The remaining 6 LCC packs will have 3 text-only warnings, with 3 images containing the "Sweet" flavor and 3 images without a flavor. We will measure attention to the warnings and attention to the flavor descriptors as well as electrodermal activity and affective responses for each of the 12 stimuli.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LCC Package with pictorial warning and no flavor

Participants will see a mock LCC package with pictorial warnings and no flavor descriptor.

Group Type EXPERIMENTAL

pictorial warning and no flavor

Intervention Type BEHAVIORAL

LCC Package with pictorial warning and no flavor

LCC Package with pictorial warning and 'sweet' flavor

Participants will see a mock LCC package with pictorial warnings and a 'sweet' flavor descriptor.

Group Type EXPERIMENTAL

pictorial warning and 'sweet' flavor

Intervention Type BEHAVIORAL

LCC Package with pictorial warning and 'sweet' flavor

LCC Package with text-only warning and no flavor

Participants will see a mock LCC package with text-only warnings and no flavor descriptor.

Group Type EXPERIMENTAL

text-only warning and no flavor

Intervention Type BEHAVIORAL

LCC Package with text-only warning and no flavor

LCC Package with text-only warning and 'sweet' flavor

Participants will see a mock LCC package with text-only warnings and a 'sweet' flavor descriptor

Group Type EXPERIMENTAL

text-only warning and 'sweet' flavor

Intervention Type BEHAVIORAL

LCC Package with text-only warning and 'sweet' flavor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pictorial warning and no flavor

LCC Package with pictorial warning and no flavor

Intervention Type BEHAVIORAL

pictorial warning and 'sweet' flavor

LCC Package with pictorial warning and 'sweet' flavor

Intervention Type BEHAVIORAL

text-only warning and no flavor

LCC Package with text-only warning and no flavor

Intervention Type BEHAVIORAL

text-only warning and 'sweet' flavor

LCC Package with text-only warning and 'sweet' flavor

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 21 years old
* Pass quality/bot screening (will answer honestly, captcha, simple math question)
* Speak English
* Current every day or some day users of LCC products
* Able to come to an appointment in NC triangle area
* Do not have any eye conditions that prevent them from being eye tracked (e.g., glaucoma, lazy eye, bifocals)

Exclusion Criteria

* Under 21 years old
* Do not speak English
* Unable to pass quality/bot screening
* Unable to come to an appointment
* Eye conditions that prevent eye tracking (e.g., glaucoma, lazy eye, bifocals)
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Food and Drug Administration (FDA)

FED

Sponsor Role collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam O Goldstein

Role: PRINCIPAL_INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://unclineberger.org/patientcare/clinical-trials/clinical-trials

University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01CA240732

Identifier Type: NIH

Identifier Source: secondary_id

View Link

24-0841

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cigar Packaging Study
NCT04605874 COMPLETED NA
Impact of Aversive Warnings on E-Cigarette Cessation
NCT05892445 NOT_YET_RECRUITING PHASE3